RA Capital Management Shows New 6.1% Stake in Anthera Pharmaceuticals (ANTH)
Tweet Send to a Friend
Down)
In a 13G filing on Anthera Pharmaceuticals (NASDAQ: ANTH), Peter Kolchinsky's hedge fund RA Capital Management LLC disclosed a 6.07%, or 4,500,000 share, stake in the company. The stake comes following completion of a recent 33 million share offering.
The firm did not hold shares at the end of the latest quarter ending March 31, 2012.
For more notable holders of Anthera Pharmaceuticals stock click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm did not hold shares at the end of the latest quarter ending March 31, 2012.
For more notable holders of Anthera Pharmaceuticals stock click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Kyle Bass 13G Shows 9.7% Stake in Dex Media (DXM)
- Tessera (TSRA), Starboard Reach Agreement Over Board Composition
- Paulson in Favor of Amended Plains Exploration (PXP), Freeport (FCX) Merger
Create E-mail Alert Related Categories
13Gs, Hedge FundsRelated Entities
Hedge Funds, 13G
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
